Form 4: Organon CEO Kevin Ali Reports Stock Transactions
SEC Form 4 Filing
CEO Kevin Ali reports the vesting and distribution of restricted stock units and subsequent tax withholding.
Summary
- On February 28, 2024, Kevin Ali, CEO of Organon & Co., reported transactions involving Organon's common stock.
- 88,121 Restricted Stock Units (RSUs) vested on December 31, 2023, and were converted into shares of common stock on February 28, 2024.
- Simultaneously, 40,414 shares were withheld for tax purposes at a price of $18.04 per share.
- Following these transactions, Ali directly owns 98,326 shares of Organon & Co. common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as this is a routine reporting of stock transactions related to executive compensation.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- Shareholders are informed about the CEO's stock transactions, promoting transparency.
Key Dates
| Date | Description |
|---|---|
| 12/31/2023 | Restricted Stock Units vested |
| 02/28/2024 | RSUs converted to common stock and shares withheld for taxes |
| 03/01/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.